| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 50.0361 | 49 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.0837 | 37 |
| GSM780709 | Untreated after 4 days (C3_1) | 51.3276 | 52 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.6089 | 20 |
| GSM780720 | Untreated after 4 days (C2_2) | 54.6346 | 59 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.8755 | 48 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.9566 | 45 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.2645 | 28 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.9334 | 32 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 50.547 | 50 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 52.4845 | 55 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.5781 | 53 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 49.3722 | 46 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.6529 | 35 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.79 | 26 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.9896 | 37 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 53.9527 | 58 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.2449 | 46 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 50.9152 | 51 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.6489 | 30 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 52.3832 | 55 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 52.2133 | 54 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 54.0375 | 58 |